| Chitosan membrane as a wound‐healing dressing: characterization and clinical application AK Azad, N Sermsintham, S Chandrkrachang, WF Stevens Journal of Biomedical Materials Research Part B: Applied Biomaterials: An …, 2004 | 516 | 2004 |
| Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer L Li, S Karanika, G Yang, J Wang, S Park, BM Broom, GC Manyam, W Wu, ... Science signaling 10 (480), eaam7479, 2017 | 272 | 2017 |
| Mutations in the amiloride‐sensitive epithelial sodium channel in patients with cystic fibrosis‐like disease AK Azad, R Rauh, F Vermeulen, M Jaspers, J Korbmacher, B Boissier, ... Human mutation 30 (7), 1093-1103, 2009 | 108 | 2009 |
| A mutation of the epithelial sodium channel associated with atypical cystic fibrosis increases channel open probability and reduces Na+ self inhibition R Rauh, A Diakov, A Tzschoppe, J Korbmacher, AK Azad, H Cuppens, ... The Journal of physiology 588 (8), 1211-1225, 2010 | 102 | 2010 |
| Targeting the MYCN–PARP–DNA damage response pathway in neuroendocrine prostate cancer W Zhang, B Liu, W Wu, L Li, BM Broom, SP Basourakos, D Korentzelos, ... Clinical Cancer Research 24 (3), 696-707, 2018 | 84 | 2018 |
| Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis L Eng, AK Azad, S Habbous, V Pang, W Xu, AH Maitland-van Der Zee, ... Clinical cancer research 18 (17), 4526-4537, 2012 | 63 | 2012 |
| Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk G Liu, S Gramling, D Munoz, D Cheng, AK Azad, M Mirshams, Z Chen, ... Oncogene 30 (29), 3295-3304, 2011 | 61 | 2011 |
| Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival AK Azad, I Bairati, E Samson, D Cheng, M Mirshams, X Qiu, S Savas, ... Clinical Cancer Research 18 (1), 196-206, 2012 | 47 | 2012 |
| Pharmacogenetic and germline prognostic markers of lung cancer AM Horgan, B Yang, AK Azad, E Amir, T John, DW Cescon, ... Journal of Thoracic Oncology 6 (2), 296-304, 2011 | 47 | 2011 |
| Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration‐resistant prostate cancer models Y Luo, AK Azad, S Karanika, SP Basourakos, X Zuo, J Wang, L Yang, ... International journal of cancer 142 (10), 2163-2174, 2018 | 43 | 2018 |
| Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium … L Mutesa, AK Azad, C Verhaeghe, K Segers, JF Vanbellinghen, ... Chest 135 (5), 1233-1242, 2009 | 42 | 2009 |
| Cancer patients’ acceptance, understanding, and willingness-to-pay for pharmacogenomic testing S Cuffe, H Hon, X Qiu, K Tobros, CKA Wong, B De Souza, G McFarlane, ... Pharmacogenetics and genomics 24 (7), 348-355, 2014 | 40 | 2014 |
| Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk JR Wang, SJB Gramling, DP Goldstein, D Cheng, D Chen, AK Azad, ... Carcinogenesis 34 (5), 1012-1017, 2013 | 39 | 2013 |
| Functional characterization of a partial loss-of-function mutation of the epithelial sodium channel (ENaC) associated with atypical cystic fibrosis R Huber, B Krueger, A Diakov, J Korbmacher, S Haerteis, J Einsiedel, ... Cellular Physiology and Biochemistry 25 (1), 145-158, 2009 | 38 | 2009 |
| AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas CD May, J Garnett, XY Ma, SM Landers, DR Ingram, EG Demicco, ... BMC Cancer 15 (1), 901-912, 2015 | 31 | 2015 |
| Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients AK Azad, I Bairati, X Qiu, H Huang, D Cheng, G Liu, F Meyer, A Adjei, ... International journal of cancer 132 (11), 2520-2527, 2013 | 25 | 2013 |
| Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers AK Azad, I Bairati, E Samson, D Cheng, L Cheng, M Mirshams, S Savas, ... Cancer 118 (6), 1554-1565, 2012 | 25 | 2012 |
| HLA-B* 07 is a high risk allele for familial cervical cancer X Qiu, F Zhang, D Chen, AK Azad, L Zhang, Y Yuan, Z Jiang, W Liu, Y Tan, ... Asian Pac J Cancer Prev 12 (10), 2597-600, 2011 | 19 | 2011 |
| Two BRM promoter insertion polymorphisms increase the risk of early‐stage upper aerodigestive tract cancers KM Wong, X Qiu, D Cheng, AK Azad, S Habbous, P Palepu, M Mirshams, ... Cancer Medicine 3 (2), 426-433, 2014 | 18 | 2014 |
| Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome L Eng, AK Azad, X Qiu, QQ Kong, D Cheng, N Ying, A Tse, Q Kuang, ... Carcinogenesis 36 (9), 956-962, 2015 | 16 | 2015 |
Wei Xu, PhDProfessor of Biostatistics, University of Toronto在 uhnres.utoronto.ca 的电子邮件经过验证
